Key stats
- Market cap
- 57.9B
- Open
- —
- Day range
- —
- 52-week range
- $140.11 – $221.55
- Volume
- 1.40M
- Avg volume
- 1.86M
Q4 FY26Beat
Expected$4.11
Actual$4.15
BDX
Becton, Dickinson and Company$212.65-$2.60-1.21%Price as of Nov 10, 2026, 6:00 PM ET
Earnings
Q3 FY26
Actual$1.37
Q2 FY26
Actual$-1.11
Q1 FY26
Actual$1.34
About
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
- Employees
- 72,000
- Headquarters
- Franklin Lakes, NJ